Page last updated: 2024-09-04

docetaxel anhydrous and isocoumarin nm-3

docetaxel anhydrous has been researched along with isocoumarin nm-3 in 1 studies

Compound Research Comparison

Studies (docetaxel anhydrous)	Trials (docetaxel anhydrous)	Recent Studies (post-2010) (docetaxel anhydrous)	Studies (isocoumarin nm-3)	Trials (isocoumarin nm-3)	Recent Studies (post-2010) (isocoumarin nm-3)
12,110	3,216	6,920	16	0	0

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Agata, N; Bamberg, M; Kharbanda, S; Kufe, D; Milhollen, M; Nogi, H; Pu, M; Weitman, S	1

Other Studies

1 other study(ies) available for docetaxel anhydrous and isocoumarin nm-3

Article	Year
The angiogenesis inhibitor NM-3 is active against human NSCLC xenografts alone and in combination with docetaxel. Cancer chemotherapy and pharmacology, 2005, Volume: 56, Issue:6 Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Survival; Docetaxel; Drug Screening Assays, Antitumor; Humans; Isocoumarins; Lung Neoplasms; Mice; Mice, Nude; Neoplasms, Experimental; Taxoids	2005

Article

Year

The angiogenesis inhibitor NM-3 is active against human NSCLC xenografts alone and in combination with docetaxel.

Cancer chemotherapy and pharmacology, 2005, Volume: 56, Issue:6

Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Survival; Docetaxel; Drug Screening Assays, Antitumor; Humans; Isocoumarins; Lung Neoplasms; Mice; Mice, Nude; Neoplasms, Experimental; Taxoids

2005